Joanna Breitstein
Joanna Breitstein
Executive Editor
jbreitstein@advanstar.com
Joanna Breitstein is executive editor at Pharmaceutical Executive magazine, and has been with the publication since November 2000. During that time, she's interviewed countless CEOs and other pharma executives for cover stories and feature articles on all aspects of the development and commercialization of pharmaceuticals. In 2004, Joanna won a fellowship from the Kaiser Family Foundation to travel to Africa and report on AIDS drug distribution under President Bush's PEPFAR grant, resulting in a two-part series on the topic. Joanna also won a Neal Award, for excellence in business journalism, in 2002 for her cover story focusing on the coverage of diagnostics and pharmaceuticals, and a Grand Neal Award in 2001, for a cover story on patient advocacy in oncology. Before joining Pharmaceutical Executive, Joanna deepened her knowledge of the pharma industry and several treatment categories within the health and medical group at Ogilvy Public Relations Worldwide. She is also president of the international HUG Foundation, a 501c3 organization whose mission is to help needy orphans in Uganda.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
